Prior Authorization Services for Infectious Disease Drugs and Infusion Therapy

Payment posting is the process of recording payer and patient payments in a practice’s billing system after claims are processed. The work generally includes matching payments to the correct claim, documenting adjustments and denials, and identifying balances that remain unresolved. Accurate posting helps the practice understand what was paid, what is still due, and whether reimbursement aligns with the expected claim outcome.

In medical billing, payment posting updates the patient account and practice records when a payer or patient payment is received. It may include applying the payment, recording contractual adjustments, identifying remaining balances, and documenting denial or remark information from the explanation of benefits. For infectious disease practices, accurate posting supports review of drug, administration, evaluation and management, and other related claim activity.

Prior authorization can determine whether a payer will approve a drug, infusion, specialty medication, or OPAT course before treatment proceeds. If eligibility, benefit classification, clinical documentation, or payer requirements are not addressed correctly, the practice may face a denial or unreimbursed drug expense. A structured authorization workflow helps connect the clinical plan with the payer’s coverage and documentation requirements.

Authorization support can include verifying eligibility and benefits, determining whether therapy falls under the medical or pharmacy benefit, preparing and submitting prior authorization requests, tracking request status, and organizing supporting documentation. The exact work depends on the therapy, payer, practice workflow, and available clinical information. The objective is to make authorization responsibilities visible and reduce preventable gaps before billing occurs.

Yes. The service catalog specifically includes prior authorization support for infusions, OPAT courses, and specialty drugs. Support may also involve benefit verification and classification between medical and pharmacy coverage. Practices should still confirm the payer’s current requirements and provide the clinical documentation requested for the particular therapy, because authorization rules and covered benefits can vary by plan.

Practices can reduce authorization-related denials by confirming eligibility, identifying the applicable benefit, submitting complete supporting documentation, and tracking requests through resolution. Reviewing denial patterns can also reveal recurring issues involving missing authorization, medical-versus-pharmacy benefit confusion, drug coding, or documentation. Connecting these findings to clinical, coding, and front-office workflows helps address root causes rather than repeatedly correcting the same claim problem.

Yes. Eligibility and benefit verification are part of the listed support service. The work is intended to clarify whether coverage is active and whether the planned infectious disease drug or infusion is handled under the medical or pharmacy benefit. Verification does not guarantee payment, because coverage remains subject to payer policy, authorization decisions, documentation, coding, and the terms of the applicable plan.

Yes. Authorization issues can be reviewed alongside documentation, coding, drug and infusion billing, denials, underpayments, accounts receivable, and payer agreements. This broader view can help a practice identify where revenue is delayed, denied, or left uncollected. GrowInfectiousDisease provides guidance and tools for evaluating these mechanics, while practice-specific conclusions require the organization’s own operational and financial information.